Evonik
Prema Latha has extensive experience in financial analysis and management, currently serving as a Senior Financial Planning Analyst at SC Johnson since October 2018, where collaboration with APAC cluster supply chain teams focuses on logistics cost improvement and inventory management. Prema has also held the position of Senior Finance Officer at Evonik since May 2016 and worked as a Senior Financial Analyst at GlaxoSmithKline Pharma GmbH from May 2014 to May 2016, receiving a Silver Award for excellence in system migration. Prior experience includes a Senior Analyst role at AMWAY Business Services Asia Pacific, where significant contributions were made to General Ledger activities and a successful transition project in Australia and New Zealand. Prema holds a Master's degree in Business Administration and Management from Cardiff Metropolitan University and a Bachelor's degree in Accounting and Finance from UNITAR Education Group.
This person is not in any offices
Evonik
11 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.